United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - metolazone - oral solution - 100microgram/1ml

United States - English - NLM (National Library of Medicine)

a-s medication solutions - metolazone (unii: tz7v40x7vx) (metolazone - unii:tz7v40x7vx) - metolazone tablets, usp, are indicated for the treatment of salt and water retention including: · edema accompanying congestive heart failure; · edema accompanying renal diseases, including the nephrotic syndrome and states of diminished renal function. metolazone tablets, usp, are also indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class. mykrox tablets, a more rapidly available form of metolazone, are intended for the treatment of new patients with mild to moderate hypertension. a dose titration is necessary if mykrox tablets are to be substituted for metolazone tablets, usp, in the treatment of hypertension. see package circular for mykrox tablets. usage in pregnancy the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no evidence that they are useful in the treatment of developed toxemia.

United States - English - NLM (National Library of Medicine)

a-s medication solutions - metolazone (unii: tz7v40x7vx) (metolazone - unii:tz7v40x7vx) - metolazone tablets, usp, are indicated for the treatment of salt and water retention including: - edema accompanying congestive heart failure; - edema accompanying renal diseases, including the nephrotic syndrome and states of diminished renal function. metolazone tablets, usp, are also indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class. mykrox tablets, a more rapidly available form of metolazone, are intended for the treatment of new patients with mild to moderate hypertension. a dose titration is necessary if mykrox tablets are to be substituted for metolazone tablets, usp, in the treatment of hypertension. see package circular for mykrox tablets. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathologic causes or from the physiologic and mechanical consequences of pregnancy. metolazone tablets, usp, are indicated in pregnancy when edema is due to pathologic causes, just as it is in the absence of pregnancy (see precautions). dependent edema in pregnancy resulting from restriction of venous return by the expanded uterus is properly treated through elevation of the lower extremities and use of support hose; use of diuretics to lower intravascular volume in this case is illogical and unnecessary. there is hypervolemia during normal pregnancy which is harmful to neither the fetus nor the mother (in the absence of cardiovascular disease), but which is associated with edema, including generalized edema, in the majority of pregnant women. if this edema produces discomfort, increased recumbency will often provide relief. in rare instances, this edema may cause extreme discomfort which is not relieved by rest. in these cases, a short course of diuretics may be appropriate. anuria, hepatic coma or precoma, known allergy or hypersensitivity to metolazone.

Uganda - English - National Drug Authority

centaur pharmaceuticals private limited - metolazone tablets usp - oral solid ordinary tablets - 2.5mg

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ciclosporin, quantity: 25 mg - capsule, soft - excipient ingredients: gelatin; iron oxide black; polysorbate 20; purified water; ethyl lactate; sorbitan oleate; titanium dioxide; peg-40 hydrogenated castor oil; glycerol; tricaprin; lecithin - ciclosporin is indicated: ? as an immunosuppressive agent for the prevention of graft rejection following kidney, liver and heart allogeneic transplantation. ? for induction and/or maintenance of remission in the nephrotic syndrome. ciclosporin is not a first-line agent. its use should be restricted to occasions when steroids and cytostatic drugs have failed, or are not tolerated, or are considered inappropriate, and when renal function is unimpaired (see section 4.4 special warnings and precautions for use). ? for the treatment of severe, active rheumatoid arthritis in patients for whom classical slow-acting antirheumatic agents (including methotrexate) are inappropriate or ineffective. ? in patients with severe psoriasis in whom conventional therapy is ineffective or inappropriate and the disease has caused a significant interference with quality of life. ? for the treatment of severe atopic dermatitis when other treatment is ineffective or inappropriate.,careful monitoring of all ciclosporin-treated patients is mandatory. ciclosporin should only be used by medical practitioners who are experienced in the use of immunosuppressive therapy (see section 4.4 special warnings and precautions for use).

Namibia - English - Namibia Medicines Regulatory Council

novartis south africa (pty) ltd - metolazone - tablet - 2.5 mg/tablet

Bangladesh - English - DGDA (Directorate General of Drug Administration)

unimed unihealth pharmaceuticals ltd. - metolazone - tablet - 5 mg

Kenya - English - Pharmacy and Poisons Board

centaur pharmaceuticals pvt. ltd. centaur house near grand hyatt vakola santacruz - metolazone - tablet - metolazone 2.5mg - low-ceiling diuretics excluding thiazides: plain

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

1mmol/ml) oral solution (thame laboratories ltd - sodium chloride - oral solution - 58.5mg/1ml

Israel - English - Ministry of Health

rafa laboratories ltd - metolazone 5 mg - tablets - metolazone - for the treatment of salt and water retention including: edema accompanying congestive heart failure, edema accompanying renal diseases, including the nephrotic syndrome and states of diminished renal function. for hypertension, alone or in combination with other antihypertensive drugs of a different class.